Researchers have developed several Tau transgenic mouse lines, which have primarily been used to study the role of Tau in other disorders, such as Alzheimer’s Disease and Frontotemporal Dementia (Denk and Wade-Martins 2009). The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.